Truist Financial raised its price target on CVS Health stock, with MarketBeat aggregating analyst ratings.
1 report, 1 independent
Updated Sep 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Truist Financial raised its price target on CVS Health stock, with MarketBeat aggregating analyst ratings.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
CVS Health
company
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
-
MarketBeat
American personal finance blog
Related events
- MarketBeat provided stock average ratings while Leerink Partners upgraded and Barclays raised its price objective for Summit Therapeutics.
- MarketBeat provided consensus ratings and target prices regarding Duke Capital Limited on August 12, 2026.
- MarketBeat reported an average stock rating for Superior Group of Companies.
- MarketBeat reported average rating data as Barclays raised its price target and TD Cowen raised its price target for Brinker International.
- MarketBeat reported the stock consensus rating for Stabilis Solutions.